Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services

August 19, 2011 5:43 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 19, 2011 /PRNewswire-USNewswire/ -- As Medicare expands a controversial "competitive" bidding program for home medical equipment and services, economists, consumer groups, and members of Congress have gone on record to oppose that program citing reduced patient access to...

Nyx Devices' sleep-monitoring shirt attracts $500K

August 19, 2011 7:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

MIT researchers have developed sleep-monitoring technology in the form of an electronic T-shirt, and now their company, Nyx Devices Inc., is reaping the benefits. The startup announced in a regulatory filing Thursday that it has secured a $500,000 financing via equity and securities.

Syndax scores EU patent for potential cancer therapeutic

August 17, 2011 10:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Syndax Pharmaceuticals Inc. has been granted a patent from the European Patent Office for an oral HDAC inhibitor, called entinostat, to treat metastatic breast cancer and advanced non-small cell lung cancer.

Advertisement

Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year

August 16, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Aug. 16, 2011 /PRNewswire-USNewswire/ -- Seattle Children's Research Institute today announced the receipt of a two-year, $2.3 million grant from the Bill & Melinda Gates Foundation to complete prototype development of its new respiratory support device, called Seattle...

Pulmatrix pulls in $14M in Series B round

August 15, 2011 5:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Pulmatrix Inc., a Lexington biotechnology company focused on respiratory diseases, has taken in $14 million in a Series B1 funding round, from all previous including Polaris Venture Partners, 5AM Ventures, Arch Venture Partners, and Novartis Venture Fund.

Mylan Launches Generic Version of Uroxatral® Tablets

August 12, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Aug. 12, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg. This product is the generic version of Uroxatral®, a treatment for signs and symptoms of benign...

China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results

August 11, 2011 3:42 am | by Bio-Medicine.Org | News | Comments

HAIKOU CITY, China, Aug. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI ) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended June 30, 2011. Second Quarter 2011...

Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation(2)

August 10, 2011 4:39 am | by Boston Scientific | News | Comments

Company also introduces industry's first iPhone®/iPad® app for healthcare professionals using SCS

Advertisement

Study of Tricuspid Valve Mechanics Uncovers Causes for Leakage

August 9, 2011 8:40 am | by Georgia Tech Institute of Technology | News | Comments

Millions experience leakage from their heart's tricuspid valve, but what causes it is not well understood. A new study found that either dilating the valve opening or displacing the papillary muscles that control its operation can cause the valve to leak.

Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems

August 9, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Aug. 9, 2011 /- Medical physicists researching RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR ) have reported that, compared with conventional approaches to radiotherapy, RapidArc treatment plans for lung, abdominal and spinal...

Global Health Ventures August 4th Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

August 8, 2011 11:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 8, 2011 /- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that their August 4th RetailInvestorConferences.com presentation by Dr. Hassan Salari PhD, Chairman and CEO, is available for...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011

August 8, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

MONMOUTH JUNCTION, N.J., Aug. 8, 2011 /- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the second quarter and six-months ended June 30, 2011. Key Recent Highlights: Announced positive results through six cycles of data from the open-label...

South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeamâ„¢ Radiotherapy System from Varian Medical Systems

August 5, 2011 8:43 am | by Bio-Medicine.Org | News | Comments

BOCA RATON and JUPITER, Fla., Aug. 5, 2011 /- In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating...

Advertisement

Mold exposure during infancy increases asthma risk

August 4, 2011 7:33 am | by EurekAlert | News | Comments

(University of Cincinnati Academic Health Center) Infants who live in "moldy" homes are three times more likely to develop asthma by age 7 -- an age that children can be accurately diagnosed with the condition.

Dehaier Medical to Report Second Quarter 2011 Financial Results on August 15

August 4, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 4, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

PRA Expert's Pulmonary Function Textbook Reissued

August 2, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 2, 2011 /- PRA, a leading Clinical Research Organization, announces that the third edition of respiratory care expert Jack Wanger's book, Pulmonary Function Testing: A Practical Approach , has recently been published by Jones & Bartlett Learning in Sudbury, MA. Mr....

MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®

August 2, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 2, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and...

Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

August 1, 2011 4:42 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 1, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts...

The Pulmonary Hypertension Association and MedicAlert Foundation Form Alliance to Safeguard Patients

July 28, 2011 12:40 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 28, 2011 /PRNewswire-USNewswire/ -- Furthering their efforts to provide support to pulmonary hypertension (PH) patients, the Pulmonary Hypertension Association (PHA) has entered into a partnership with MedicAlert Foundation that will offer PHA members a discount...

Boca Raton Regional Hospital Treats Over 100 Patients Annually with CIVCO's Proturaâ„¢

July 27, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

KALONA, Iowa, July 27, 2011 /- Lynn Cancer Institute at Boca Raton Regional Hospital has established itself as a premier Protura user. Medical Director Dr. Tim Williams and his team have treated over 100 patients using Protura, and the team is presenting a poster titled "Clinical Efficacy...

Vapotherm Announces Commercial Launch of Flowrest® Homecare Device

July 26, 2011 8:38 am | by Bio-Medicine.Org | News | Comments

STEVENSVILLE, Md., July 26, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today the launch of Flowrest®, a High Flow Therapy device developed specifically for homecare and other low acuity environments. The initial launch will focus on the U.S. and European markets. Vapotherm's...

Five Leading Academic Hospitals Install the CyberKnife System for Dedicated Radiosurgery

July 25, 2011 6:37 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., July 25, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced today installation of the CyberKnife® Robotic Radiosurgery System at five renowned academic oncology centers in Europe and the United States, including the Penn...

BU names Allegro founder Spira its Innovator of the Year

July 20, 2011 5:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

At last night's Tech, Drugs and Rock & Roll annual networking event, Boston University named School of Medicine associate professor Avrum Spira the university's 2011 Innovator of the Year.

German Patient Surpasses 5 Years of Support on DuraHeartâ„¢ Left Ventricular Assist Device

July 19, 2011 3:40 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., July 19, 2011 /- Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that a patient implanted with the DuraHeart™ Left Ventricular Assist System (LVAS) has surpassed five years of support on the mechanical circulatory support...

FDA Approves Vaccines for the 2011-2012 Influenza Season

July 18, 2011 10:47 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., July 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading